HUMAN GENE TRANSFER/THERAPY PROTOCOL 
9007-002 
Blaese, R. Michael, National Cancer Institute; Treatment of Severe 
Combined Immune Deficiency (SCID) due to Adenosine Deaminase 
(ADA) Deficiency with CD34(+) Selected Autologous Hematopoietic 
Stem Cells 
Date of RAC Approval: 7/31/90 
Date of NIH Approval: 9/6/90 
Major Amendment-Date of RAC Approval: 2/10-11/92 
Major Amendment-Date of NIH Approval: 4/22/92 
Recombinant DNA Research, Volume 14 
[ 207 ] 
